SAN DIEGO, Oct. 31, 2016 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in California on behalf of certain purchasers of shares of Tyson Foods, Inc. (NYSE:TSN) over alleged Securities Laws Violations by Tyson Foods. The lawsuit seeks to recover damages for certain NYSE:TSN investors.
Investors who purchased shares of Tyson Foods, Inc. (NYSE:TSN) have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff alleges that Tyson Foods had conspired to fix chicken prices and that, as a result, defendants' statements were allegedly materially false and misleading at all relevant times.
On September 2, 2016, certain media outlets reported the filing of an antitrust lawsuit against Tyson Foods asserting that it conspired to manipulate the price of broiler-chickens.
On October 7, 2016, Pivotal Research downgraded Tyson Foods, Inc. from "buy" to "sell," noting apprehensions about a "powerfully convincing" class action against Tyson Foods, Inc. and some of its industry peers as defendants, alleging price collusion in the broiler-chicken market. The complaint alleges that at the beginning of 2008, Tyson Foods, Inc. and several other companies conspired by sharing proprietary data and reducing production to support prices.
Those who purchased Tyson Foods, Inc. (NYSE:TSN) shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 [email protected] 3111 Camino Del Rio North Suite 423 San Diego, CA 92108


BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy 



